Navigation auf uzh.ch
Navigation auf uzh.ch
Novartis is seeking cutting-edge academic collaborations aligned with their Biomedical Research portfolio.:
Disease Areas & Technology platforms of interest:
If you have an exciting project in these fields and are interested in an industry collaboration, reach out to Corina Mueller at corina.mueller3@uzh.ch to discuss in more detail how your research aligns with Novartis’ priorities and kickstart the conversation.
Do you have a clear experimental plan on how to validate your disease-relevant hypothesis, but need funding to translate your idea into a new medicine? Science2Medicine validatioNN is a programme created to support innovators like you:
• Funding: quick review process (<1 month); allotment of up to 50,000 Euros for 6–9 months of work to validate your translational idea
• Expert advice: feedback from Novo Nordisk drug discovery/ development experts without ownership claim: you keep IP rights and freedom to publish your research
• Resources: access to Novo Nordisk open innovation compounds/reagents
• Gateway to future collaboration: a foundational partnership with potential for future/long-term collaboratio
Disease areas: Diabetes | Obesity | Cardiovascular Disease | Kidney Disease | Liver Disease (NASH) | Rare Disease
read more and apply here
For support with the application you can contact corina.mueller3@uzh.ch. For questions related to IP and confidentiality, please reach out to your Unitectra contact (or mail@unitectra.ch if you don’t have a contact yet)
Boehringer Ingelheim is looking for researchers with innovative approaches to address unmet medical needs. From molecules, to funding, to direct cooperation, to molecular biology questions and technology partnerships; they offer a range of collaborative initiatives and resources aimed at transforming lives for generations.
opn2EXPERTS: invitation to explore precisely formulated biological questions that are open for expert responses, which can lead to research funding
techMATCH: Join techMATCH and propel drug discovery and development forward with your innovative technology solutions. Winners will benefit from a long-term, collaborative partnership, that provides access to Boehringer's expertise and the prospect of research funding
Didn’t find what you’re looking for? Reach out to corina.mueller3@uzh.ch, and we’ll help you explore tailored options
